Search
Now showing items 1-2 of 2
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
(Frontiers Media, 2022-01-02)
[Abstract] The EMPA-REG OUTCOME (Empagliflozin, Cardiovascular Outcome Event Trial in patients with Type 2 Diabetes Mellitus (T2DM)) trial evidenced the potential of sodium-glucose cotransporter 2 (SGLT2) inhibitors for ...
Effect of different plasticizers on thermal, crystalline, and permeability properties of Poly(3–hydroxybutyrate–co-3–hydroxyhexanoate)films
(MDPI, 2022-08-22)
Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBH) films were prepared using a cast film technique. Dioxane was chosen over other polymer solvents as it resulted in homogenous films with better morphology. Several ...
